qtr-three adjusted loss per share $num-one excluding items.
qtr-three loss per share $num-one.
qtrly medical end-use sales were down num-one% sequentially as customers continue to manage inventory levels.
qtr-two sales $num-one million versus refinitiv ibes estimate of $1.22 billion.
sees qtr-three year-six earnings per share to be in range of $num-one% to $2.00.
qtr-one adjusted operating loss per share $num-one.
qtrly sales excluding surcharge decreased num-one% sequentially.
qtrly sales excluding surcharge decreased num-one% on a non-gaap basis.
qtr-three operating loss per share $num-one.
qtr-two sales $num-one billion versus refinitiv ibes estimate of $1.8 billion.
qtr-three sales $num-one million versus refinitiv ibes estimate of $1.32 billion.
qtrly u.s. vehicle inventory remains below num-one days of supply, down approximately num-two% year-over-year.
qtr-three sales $num-one million versus refinitiv ibes estimate of $1.35 billion.
qtrly sales decreased num-one% on a num-two% decrease in volume.
qtr-three year-six earnings per share $num-one excluding items.
qtr-two adjusted earnings per share $num-one.
